Covered recipient · General Payments record
ROBERT C SOLOMON
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2018–2024
$1,589.90
- Reported across 98 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $560.61 | 29 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $275.03 | 15 |
| Novo Nordisk AS | $98.36 | 4 |
| Lilly USA, LLC | $75.37 | 4 |
| ITI, Inc. | $69.11 | 3 |
| Abbott Laboratories | $28.55 | 2 |
| DEXCOM, INC. | $14.19 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (29)
Sorted by paying entity, then date · as published by CMS
Program year 2024 20182019202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $14.73 | 03/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125331082 | CMS |
| Abbott Laboratories | $13.82 | 12/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125331084 | CMS |
| ABBVIE INC. | $5.96 | 01/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106136580 | CMS |
| ABBVIE INC. | $18.17 | 01/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106136582 | CMS |
| ABBVIE INC. | $13.47 | 02/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106136584 | CMS |
| ABBVIE INC. | $21.38 | 02/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106136586 | CMS |
| ABBVIE INC. | $4.92 | 03/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106136588 | CMS |
| ABBVIE INC. | $18.58 | 04/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106136590 | CMS |
| ABBVIE INC. | $15.50 | 04/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106136592 | CMS |
| ABBVIE INC. | $22.44 | 05/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106136594 | CMS |
| ABBVIE INC. | $31.26 | 05/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106136596 | CMS |
| ABBVIE INC. | $7.45 | 06/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106136598 | CMS |
| ABBVIE INC. | $32.52 | 06/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106136600 | CMS |
| ABBVIE INC. | $19.65 | 08/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106136602 | CMS |
| ABBVIE INC. | $23.04 | 08/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106136604 | CMS |
| ABBVIE INC. | $17.43 | 10/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106136606 | CMS |
| ABBVIE INC. | $23.26 | 11/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106136608 | CMS |
| Dexcom, Inc. | $14.19 | 07/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153331853 | CMS |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $21.90 | 10/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143324854 | CMS |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $22.22 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143324858 | CMS |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $24.99 | 11/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143324862 | CMS |
| Lilly USA, LLC | $23.01 | 02/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135394055 | CMS |
| Lilly USA, LLC | $16.14 | 08/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135394057 | CMS |
| Lilly USA, LLC | $20.16 | 09/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135394059 | CMS |
| Lilly USA, LLC | $16.06 | 11/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135355446 | CMS |
| Novo Nordisk Inc | $17.53 | 03/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096909139 | CMS |
| Novo Nordisk Inc | $32.93 | 10/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096820215 | CMS |
| Novo Nordisk Inc | $23.95 | 11/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097133851 | CMS |
| Novo Nordisk Inc | $23.95 | 12/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096764181 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.